Tag: Cell
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcino

European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcino

Not intended for US, Canada and UK-based media -- EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with ...

Lees verder
Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Tr

Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Tr

AACHEN, Germany, and MELBOURNE, Australia, Sept. 10, 2019 /PRNewswire/ -- Grünenthal, a global leader in pain management, and Mesoblast Limited , a world leader in allogeneic ...

Lees verder
Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of

Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of

Not intended for US, Canada and UK-based media DARMSTADT, Germany and NEW YORK, Feb. 16, 2019 /PRNewswire/ -- -- JAVELIN Renal 101 shows significant improvement in ...

Lees verder
Merck Receives Fast-Track Designation for Tepotinib in Non-Small Cell Lung Cancer in Japan

Merck Receives Fast-Track Designation for Tepotinib in Non-Small Cell Lung Cancer in Japan

DARMSTADT, Germany, March 27, 2018 /PRNewswire/ -- Not intended for UK- or US-based media  - Japanese Ministry of Health, Labour and Welfare Grants SAKIGAKE ...

Lees verder
FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma

FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma

DARMSTADT, Germany and NEW YORK, December 21, 2017 /PRNewswire/ -- - Second Breakthrough Therapy Designation for avelumab in hard-to-treat cancer  - Renal ...

Lees verder
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

DARMSTADT, Germany, and NEW YORK, USA, September 21, 2017 /PRNewswire/ -- Not intended for US, Canadian and UK-based media     - First approved immunotherapy for ...

Lees verder
Combination Data for Lenvatinib and Pembrolizumab Demonstrate Notable Response Rates for Patients with Advanced Renal Cell Carcinoma

Combination Data for Lenvatinib and Pembrolizumab Demonstrate Notable Response Rates for Patients with Advanced Renal Cell Carcinoma

HATFIELD, England, September 9, 2017 /PRNewswire/ -- FOR EMEA MEDICAL MEDIA ONLY - NOT FOR SWISS/AUSTRIAN JOURNALISTS  - Updated results of advanced RCC cohort from ...

Lees verder
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

DARMSTADT, Germany and NEW YORK, July 21, 2017 /PRNewswire/ -- Not intended for US, Canadian and UK-based media   - If approved, ...

Lees verder
BizPress.nl